跳到主要内容

Electromed, Inc. (ELMD) Stock Forecast 2025 - AI Price Prediction & Analysis


Electromed, Inc. (ELMD) AI Stock Price Forecast & Investment Analysis

Electromed, Inc. Stock Price Chart and Technical Analysis

Loading Electromed, Inc. interactive price chart and technical analysis...

Electromed, Inc. (ELMD) - Comprehensive Stock Analysis & Investment Research

Deep dive into Electromed, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Electromed, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Electromed, Inc.: Electromed, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Electromed, Inc. (Stock Symbol: ELMD) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 156 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Electromed, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Electromed, Inc.: With $64M in annual revenue and 4.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $64 million generating a 4.6% net profit margin .

Market Capitalization: $218 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 6.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Electromed, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Electromed, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Electromed, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Electromed, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Electromed, Inc.: Market positioning analysis based on available financial and operational metrics.

Electromed, Inc. strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 75.4% gross margin, indicating strong pricing power and operational efficiency.

Electromed, Inc. (ELMD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Electromed, Inc. stock analysis.

Loading Electromed, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Electromed, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Electromed, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Electromed, Inc.: With a P/E ratio of 28.94, the market highly values future growth prospects.

P/E Ratio 28.94x
P/B Ratio 5.05x
Market Cap $218M
EPS $0.89
Book Value/Share $4.85
Revenue/Share $7.18
FCF/Share $0.37
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Electromed, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Electromed, Inc.: An ROE of 6.9% indicates room for improvement in shareholder value creation.

ROE 6.9%
ROA 6.1%
ROIC 6.9%
Gross Margin 75.4%
Operating Margin 8.4%
Net Margin 4.6%
EBT Margin 7.9%
Tax Rate 26.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Electromed, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Electromed, Inc.: A current ratio of 6.64 indicates strong liquidity.

Current Ratio 6.64x
Quick Ratio 6.02x
D/E Ratio 0.06x
Financial Leverage 1.15x
Interest Coverage 53.6x
Working Capital $27M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Electromed, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Electromed, Inc.: Free cash flow of $-1M indicates cash challenges that need attention.

Operating Cash Flow $1M
Free Cash Flow $-1M
Capital Spending $-1M
OCF Growth YoY -26.7%
FCF Growth YoY -18.3%
FCF/Sales -1.3%
CapEx/Sales 3.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Electromed, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Electromed, Inc.: An asset turnover of 1.05x demonstrates efficient asset utilization.

Asset Turnover 1.05x
Receivables Turnover 2.2x
Inventory Turnover 4.4x
Fixed Assets Turnover 10.2x
Days Sales Outstanding 164 days
Days Inventory 83 days
Payables Period 42 days
Cash Conversion Cycle 205 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Electromed, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Electromed, Inc.: With annual revenue of $64M, Electromed, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $64M
Operating Income $1M
R&D Expense $1M
SG&A Expense $65M
Cost of Goods Sold $13M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 85%
Cash & Short-term Investments 25%
Total Liabilities 13%
Short-term Debt 4%
Accounts Receivable 51%
Inventory 5%
Dividend & Shareholder Information
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth 0.5%

Latest Electromed, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Electromed, Inc. (ELMD) stock price and investment outlook.

, source: Yahoo Finance

Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed to ...

, source: None

Electromed ( (ELMD) ) has issued an update. On September 9, 2025, Electromed, Inc. announced a new share repurchase authorization of up to $10 million following the exhaustion of its previous ...

Electromed, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Electromed, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1676M 15.2x 1.7x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1207M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3800M 46.0x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3199M -662.0x 2.9x
MASI Unlock Forecast - 30 Days FREE Trial $8169M 128.1x 7.8x
MDT Unlock Forecast - 30 Days FREE Trial $121684M 26.1x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4248M 59.3x 13.4x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - Electromed, Inc. Stock Forecast

How accurate are Electromed, Inc. stock predictions?

Our AI model demonstrates 60% historical accuracy for ELMD predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Electromed, Inc. stock price forecasts?

Our analysis considers Electromed, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Electromed, Inc. a good investment in 2025?

Based on our AI analysis, Electromed, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Electromed, Inc. forecasts updated?

Electromed, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Electromed, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Electromed, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...